B7-2+ low density APCS are as effective as B7-2- small resting B cells in inducing specific unresponsiveness to minor histocompatibility (miH) antigen(s) in vivo.
Niimi
M
M
Nuffield Department of Surgery, University of Oxford, John Radcliffe Hospital, United Kingdom.
Rawsthorne
M A
MA
Morris
P J
PJ
Wood
K J
KJ
D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology*; D015703:Antigens, CD / Q000378:metabolism*; D001402:B-Lymphocytes / Q000276:immunology*; D051940:B7-2 Antigen; D003713:Dendritic Cells / Q000276:immunology*; D005260:Female; D006082:Graft Enhancement, Immunologic; D006085:Graft Survival; D006182:H-Y Antigen; D016027:Heart Transplantation / Q000276:immunology; D007108:Immune Tolerance; D008297:Male; D008562:Membrane Glycoproteins / Q000378:metabolism*; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D015778:Minor Histocompatibility Antigens; D016038:Skin Transplantation / Q000276:immunology; D013997:Time Factors; D014184:Transplantation, Homologous
D015703:Antigens, CD; D051940:B7-2 Antigen; C497965:Cd86 protein, mouse; D006182:H-Y Antigen; D008562:Membrane Glycoproteins; D015778:Minor Histocompatibility Antigens